4

4SC
VSC

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€27.28M
EV
€25.87M
Shares Outstanding
10.91M
Beta
2.00

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About 4SC AG

gainify

4

4SC AG

VSC

4SC AG, a biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany. Its product Resminostat, an orally administered histone deacetylase inhibitor for the treatment of cutaneous T-cell l...

Sector

Industry

CEO

Loveridge, Jason

Employees

13

IPO Date

Headquarters

Fraunhoferstrasse 22, Planegg, Bavaria, 82152, Germany

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved